Objective: Little is known about the mental health outcomes of young children who experience developmental delay. The objective of this study was to assess whether delay in attaining developmental milestones was related to depressive and anxious symptoms in adolescence.
Method: The sample included 3508 Canadian children who participated in a nationally representative prospective cohort study. The person most knowledgeable about the child reported on attainment of developmental milestones spanning several developmental domains at ages 2-3. The children were followed into adolescence and self-reported depressive and anxious symptoms were used from adolescents ages 12-13. An overall assessment of developmental milestones as well as a supplementary analysis of specific categories of developmental milestones was conducted.
Results: Cohort members who displayed delayed developmental milestones in early childhood were more likely to experience higher levels of depressive and anxious symptoms as adolescents. However, there was no interaction between delayed developmental milestones and stressful life events. In the supplementary analysis, two developmental domains (self-care and speech/communication) were associated with higher levels of depressive and anxious symptoms in adolescence.
Conclusion: Delay in attainment of early developmental milestones is significantly associated with adolescent depressive and anxious symptoms.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577691 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0056804 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
The relationship between mothers with careers in higher education and child development in Indonesia.
Saudi Med J
January 2025
From the Faculty of Public Health (Yasin, Devy, Nadhiroh), Airlangga University, and from the please provide the Department of specialty (Nawawi), Airlangga University, Surabaya, Indonesia.
Objectives: To identify the association of mothers with a career in higher educati--on and their children's growth and development.
Methods: This was an analytical study with a cross-sectional design carried out at Wiraraja University, Sumenep, Indonesia, from March to August 2023. The samples were female lecturers at Wiraraja University.
The Impact of Vitamin D Supplementation Duration on Early Childhood Developmental Milestones: A Retrospective Study.
Nutrients
December 2024
Unit of Pediatric Clinic, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Background: Vitamin D plays a pivotal role in early childhood development, influencing skeletal strength, neuromuscular coordination, and neurodevelopment. This study aimed to evaluate the impact of different durations of Vitamin D supplementation on achieving developmental milestones.
Methods: A retrospective study was conducted on 209 children, divided into two cohorts based on Vitamin D supplementation duration: six months ( = 102) and twelve months ( = 107).
The Use of the Parents' Evaluation of Developmental Status and Developmental Milestones in Screening Children for Developmental Delay in India.
Children (Basel)
December 2024
Tropical Futures Institute, James Cook University, Singapore 387380, Singapore.
Background/objectives: The Parents' Evaluation of Developmental Status (PEDS) and Developmental Milestones (PEDS:DM) are cost-effective, self-report tools that can be conveniently utilized in low- and middle-income countries to screen for developmental delays in children. This study assessed the diagnostic accuracy of PEDS and PEDS:DM in distinguishing children with typical development (TD) from those with developmental disabilities (DD). It also examined the relationship between parents' general concerns and specific developmental concerns about their children.
View Article and Find Full Text PDFCase report: Clinical and genetic characterization of a novel variant causing pyridoxine-dependent epilepsy, developmental delay, and intellectual disability in two siblings.
Front Psychiatry
December 2024
Translational Genomic Department, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Background: Pathogenic variants in are associated with pyridoxine-dependent epilepsy (PDE), a rare autosomal recessive disorder characterized by epileptic seizures, unresponsiveness to standard antiseizure medications (ASM), and a response only to pyridoxine. Here, we report two patients (from a consanguineous family) with neonatal seizures and developmental delay.
Case Presentation: Patient 1 (a 13-year-old girl) was born normally at term.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!